|
Match
|
Document |
Document Title |
|
|
5334393 |
Sustained-release tablet based on isosorbide 5-mononitrate and process for preparing it
The present invention relates to a sustained-release tablet, characterized in that it comprises as active principle isosorbide 5-mononitrate (5-ISMN) in the form of a powder having a particle size...
|
|
|
5330761 |
Bioadhesive tablet for non-systemic use products
The present invention relates to a controlled release bioadhesive tablet which includes a locally active agent, a heterodisperse gum matrix, and a pharmaceutically acceptable diluent. In certain...
|
|
|
5326572 |
Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions
Freeze-dried polymer latices, which can be reconstituted in water to give aqueous polymer dispersions having high polymer solids content, are described. The reconstituted polymer dispersions are...
|
|
|
5324523 |
Controlled release pharmaceutical preparation and process for preparing same
Controlled release pharmaceutical preparations are prepared by homogenizing an organic or inorganic pharmaceutical active substance such as an opium alkaloid or its salts, an opium antagonist or...
|
|
|
5314697 |
Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the...
|
|
|
5310561 |
Antiemetic therapy
A dosage form is disclosed comprising an antiemetic and antinausea drug for treating vomiting and nausea.
|
|
|
5292518 |
Prolonged-release drug tablet formulations
A prolonged-release unit dosage formulation or pharmaceutical composition, preferably in tablet form, is described. The composition consists essentially of a gel-forming dietary fiber, a...
|
|
|
5283065 |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
A controlled release pharmaceutical composition in oral dosage unit form comprising a tablet comprising a therapeutically effective number of active spherical granules comprising an effective...
|
|
|
5275819 |
Drug loaded pollen grains with an outer coating for pulsed delivery
A pulsating release composition comprising natural microspheres, such as pollen grains or spores, into which are loaded a biologically active is subsequently releasable therefrom in a predetermined...
|
|
|
5275824 |
Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process
The described therapeutic compositions with controlled release of medicaments comprise a medicament loaded onto particles of a crosslinked non-ionic polymer insoluble but swellable in water, using...
|
|
|
5273758 |
Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
Polyethylene oxide polymer is employed as a directly compressible binder matrix for therapeutically active dosage forms. Advantageously, the polyethylene oxide has an adjustable rate control effect...
|
|
|
5268182 |
Sustained-release drug dosage units of terazosin
A sustained-release coating composition is described that contains an ethylcellulose and/or a methacrylic methylester together with a plasticizer and a detackifying agent. Sized drug granules are...
|
|
|
5268181 |
Method of using niacin to control nocturnal cholesterol synthesis
The invention provides a therapeutic method to treat hyperlipidemia by administering to a human patient a single daily dose of a prolonged release dosage form of niacin, so that nocturnal...
|
|
|
5262169 |
Tablets and granulates containing mesna as active substance
A granulate containing mesna is made by granulating mesna in the presence of an alcohol, acetone or a mixture of one of these with water. The granulate may be converted to tablets, along with other...
|
|
|
5248700 |
Active agent containing solid structures for prolonged release of active agents
A solid mixture of a degradable polymer (B) in which an active agent loaded microporous powder or granulate form polymer (A) is uniformly dispersed. The active agent loaded polymer (A) is...
|
|
|
5234691 |
Sustained-release prepararation of basic medical agent hydrochloride
A preparation obtained by coating granules containing both a basic medical agent hydrochloride (e.g. allotinolol hydrochloride) and a polyanion the particles of which are present in the form of a...
|
|
|
5217719 |
Surface-treated sodium bicarbonate particle and molded preparation thereof
Surface-treated sodium bicarbonate particles, the surfaces of which are coated with sodium carbonate or its double salt, are disclosed. Heat treatment or irradiation with micro waves o infrared...
|
|
|
5211958 |
Pharmaceutical composition and process for its preparation
A multi-purpose pharmaceutical tablet which can either be readily swallowed or dissolved in water to give a dispersion, comprising a tetracycline, microcrystalline cellulose or microfine cellulose,...
|
|
|
5211957 |
Solid rapidly disintegrating dosage form
The invention relates to a solid, rapidly disintegrating dosage form in the form of effervescent tablets for producing an aqueous suspension of diclofenac for peroral administration. The dosage...
|
|
|
5202159 |
Preparation method of microdispersed tablet formulation of spray-dried sodium diclofenac enteric-coated microcapsules
A preparation method of sodium diclofenac enteric-coated microcapsules by spray drying technique comprising the steps of (a) dissolving sodium diclofenac in an appropriate amount of distilled...
|
|
|
5200193 |
Pharmaceutical sustained release matrix and process
A pharmaceutical sustained release homogeneous tablet or homogeneous tablet layer is formed by making a wet granulation using povidone (PVP) in alcohol as the granulating fluid which is mixed with...
|
|
|
5198228 |
Direct dry compressible acetaminophen tablet
This invention relates to an analgesic composition and more particularly, to a directly dry compressible composition comprising at least about 70% by dry weight of the composition of acetaminophen...
|
|
|
5196203 |
Theophylline dosage form
A pH-dependent sustained release pharmaceutical pellet composition and a method of administering the same to a patient at a predetermined dosage and interval, said pellet composition comprising: a...
|
|
|
5188841 |
Sustained release pharmaceutical formulations
The invention provides a sustained release formulation of ketoprofen comprising granules each of which comprises a core comprising ketoprofen and microcrystalline cellulose and a coating comprising...
|
|
|
5185152 |
Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
A method and device for delivering a drug to the cornea and anterior chamber of an eye are disclosed. A drug is entrapped in microspheres of poly(lactic acid), poly(glycolic acid), a copolymer of...
|
|
|
5185159 |
Pharmaceutical composition based on valproic acid and a process for preparing it
New pharmaceutical composition based on valproic acid and one of the pharmaceutically acceptable salts thereof, obtained by a new galenic preparation process which makes it possible to improve and...
|
|
|
5169639 |
Controlled release verapamil tablets
Controlled release verapamil tablets are disclosed. The tablets include an excipient having a hydrophilic material, preferably containing a mixture of xanthan gum/locust bean gum, and an inert...
|
|
|
5164380 |
Process for preparing piroxicam/cyclodextrin complexes, the products obtained and their pharmaceutical compositions
A process for preparing complexes of piroxicam with cyclodextrins in which the two components in the powder state are premixed and then co-ground in a high energy mill in the presence of steam. The...
|
|
|
5160742 |
System for delivering an active substance for sustained release
A system for delivering an active substance has sustained release of the active substance in the intestinal tract. This delivery system is especially useful for an active substance such as a...
|
|
|
5160469 |
Manufacture of pellets of xanthine derivatives
A process for the manufacture of pellets which are composed of xanthine derivatives and are predominantly spherical, have a particle size in the range of 0.3 to 4 mm and have a bulk density above...
|
|
|
5158777 |
Captopril formulation providing increased duration of activity
A formulation comprising captopril within an enteric or delayed release coated pH stable core combined with additional captopril that is available for immediate release following administration.
|
|
|
5153002 |
Biocompatible gradient controlled release implant
A biocompatible and/or biodegradable implant for the substantially constant release, by diffusion, of a therapeutic agent in the outside medium at the site of implant which comprises a body...
|
|
|
5151273 |
Delayed-release pharmaceutical preparation
Delayed-release tablets are formed by incorporating hemicellulose and a matrix-forming adjuvant which does not disintegrate in a pharmaceutical dosage form containing the active substance or...
|
|
|
5147646 |
Hydrogel containing envelopes
An envelope having flexible water-permeable or porous walls contains a quantity of particulate water-insoluble hydrogel. The quantity of hydrogel in the envelope is such that, when the hydrogel is...
|
|
|
5137669 |
Manufacture of partially fused peptide pellet
A bioerodible pellet capable of administering an even and continuous dose of a peptide over a period of up to a year, when subcutaneously implanted, is provided. The bioerodible implant is a...
|
|
|
5135757 |
Compressible sustained release solid dosage forms
A free-flowing directly compressible granulation useful as a slow release pharmaceutical excipient is disclosed. The excipient includes a hydrodrophilic matrix which includes heteropolysaccharide...
|
|
|
5132295 |
Alginate-based verapamil-containing depot drug form
An alginate-based depot drug form for which the rate of release of the active substance in vitro can be adjusted very precisely is described.
|
|
|
5132116 |
Tablets of the hydrophilic matrix type based on salbutamol and a process for their preparation
The present invention relates to tablets of the type which contain a homogeneous dispersion of an active principle based on salbutamol or on one of its derivatives in a hydrophilic matrix,...
|
|
|
RE33994 |
Pharmaceutical delivery system
A composition for use in an aqueous environment which comprise comprises a formulation containing a water-soluble pharmaceutically beneficial agent, a water-insoluble, water-permeable film...
|
|
|
5130140 |
Method of making direct dry compressible acetaminophen composition
This invention relates to an analgesic composition and more particularly, to a directly dry compressible composition comprising at least about 70% by dry weight of the composition of acetaminophen...
|
|
|
5128143 |
Sustained release excipient and tablet formulation
A slow release pharmaceutical excipient of an inert diluent and a hydrodrophilic material including xanthan gum and a galactomannan gum capable of cross-linking the xanthan gum in the presence of...
|
|
|
5128142 |
Sustained release drug delivery system
A controlled release formulation comprising an adsorbate of a mixture of a pharmaceutically useful active ingredient and an inactive substance adsorbed on a cross-linked polymer. The inactive...
|
|
|
5126145 |
Controlled release tablet containing water soluble medicament
A sustained or controlled release tablet is disclosed. The tablet comprises a water soluble medicament, a hydroxypropyl methylcellulose having sustaining action, a pharmaceutical binding agent, and...
|
|
|
5118528 |
Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles
The process according to the invention comprises: (1) the preparation of a liquid phase consisting essentially of a solution of the substance in a solvent or in a mixture of solvents to which may...
|
|
|
5116619 |
Vaginal progesterone tablet
A vaginal progesterone suppository is provided in the form of a tablet which delivers biologically effective amounts of progesterone for at least about 48 hours, and blood amounts above basal...
|
|
|
5108759 |
Endothelial envelopment drug carriers
This application describes the preparation and in vivo testing of surface coatings and matrix materials, which when applied to or caused to comprise the carriers for drugs and diagnostic agents,...
|
|
|
5091175 |
Pharmaceutical composition containing bile acid sequestrant enclosed in a size-exclusion membrane
A pharmaceutical composition useful for treating hypercholesterolemia comprising a bile acid sequestrant resin such as cholestyramine and cholestipol maintained in a semipermeable water-insoluble...
|
|
|
5085865 |
Sustained release pharmaceutical preparations containing an analgesic and a decongestant
An orally administrable sustained-release pharmaceutical tablet having at least two layers, which are directly compressible, is disclosed. The first layer, an immediate-release layer, contains an...
|
|
|
5082667 |
Solid pharmaceutical dosage in tablet triturate form and method of producing same
A solid pharmaceutical dosage in tablet triturate form is disclosed. The tablet triturate form includes a cementatory network constituted by a water-soluble but ethanol-insoluble carbohydrate. Also...
|
|
|
5080907 |
Pharmaceutical preparations containing non-steroidal anti-inflammatory agents
Pharmaceutical preparations for oral administration are disclosed which comprise (a) an acidic non-steroidal anti-inflammatory agent having the mean particle size of about 100 μm or less and (b) a...
|